Government And Institutions

Drugmakers push profitable, but unproven, opioid solution

Pilloried for their role in the epidemic of prescription painkiller abuse, drugmakers are aggressively pushing their remedy to the problem: a new generation of harder-to-manipulate opioids that have racked up billions in sales, even though there's little proof they reduce rates of overdoses or deaths.

Iran sanctions renewal becomes law without Obama signature

In an unexpected reversal, President Barack Obama declined to sign a renewal of sanctions against Iran but let it become law anyway, in an apparent bid to alleviate Tehran's concerns that the U.S. is backsliding on the nuclear deal.

Iran sanctions renewal becomes law without Obama signature

In an unexpected reversal, President Barack Obama declined to sign a renewal of sanctions against Iran but let it become law anyway, in an apparent bid to alleviate Tehran's concerns that the U.S. is backsliding on the nuclear deal.

Highlights of new Massachusetts recreational marijuana law

A voter-approved law allowing adults to possess, grow and use limited amounts of recreational marijuana took effect Thursday in Massachusetts, but it will still be at least another year before the state issues retail licenses to sell the drug.

Highlights of new Massachusetts recreational marijuana law

A voter-approved law allowing adults to possess, grow and use limited amounts of recreational marijuana took effect Thursday in Massachusetts, but it will still be at least another year before the state issues retail licenses to sell the drug.

Federal prosecutors accuse execs of fixing drug prices

Federal prosecutors have charged two former pharmaceutical executives with fixing prices of generic drugs, part of an ongoing government investigation into anticompetitive tactics by companies that make lower-cost drugs intended to reduce medication costs.

Federal prosecutors accuse execs of fixing drug prices

Federal prosecutors have charged two former pharmaceutical executives with fixing prices of generic drugs, part of an ongoing government investigation into anticompetitive tactics by companies that make lower-cost drugs intended to reduce medication costs.

Fed Hikes Rates, Yellen Cautious About Future Economic Policies

The U.S. Federal Reserve raised interest rates by a quarter point on Wednesday and signaled a faster pace of increases in 2017 as the Trump administration takes over with promises to boost growth through tax cuts, spending and deregulation.